Use the buttons below to increase or decrease the text
Use the toggle below to switch the contrast.
Listen to the content of the page by clicking play on
To discover more about accessibility view our Accessibility
Options here to see
To all Health, facilities / all health care practitioners in Dubai's private health sector
Referring to the above subject, DHA notifies all health facilities regarding the Circular issued by the MOHAP for perusal and adhere to what is stated
Medical Product Field Safety Safety update for TNF blockers - Simponi ® (Golimumab)
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
تحديث التحذيرات على الصنف الدوائي محصرات (TNF) Simponi (Golimumab) ---.pdf:
You have shared the circular with
Could not share the circular with
Please check if you have entered valid email address
Please be advised that Sheryan doesn't support the current browser. Please use one of the recommended browsers.